Press Releases

10/31/2019

Menarini Silicon Biosystems to Debut VRNxT Technology at 25th Annual Meeting of the Association for Molecular Pathology

Automated volume reduction instrument increases precision and accuracy in rare cell workflows

continue →

Topics: Liquid biopsy, Precision Medicine, rare cells, volume reduction, VRNxT

09/23/2019

Menarini Silicon Biosystems to Host ESMO Symposium on Clinical Importance of Circulating Tumor Cells

World-renowned faculty will present current evidence and potential clinical applications of CTCs for advanced breast and prostate cancer

continue →

Topics: CTCs, Liquid biopsy, Precision Medicine, rare cells

09/19/2019

Menarini Silicon Biosystems Launches the MSBiosuite Bioinformatic Platform, Partners with BlueBee

Cloud-based solution automates NGS data analysis for liquid biopsy and FFPE workflows

continue →

07/17/2019

Menarini Silicon Biosystems Launches VRNxT Volume Reduction Instrument

Automated volume reduction increases precision and accuracy in rare cell workflows

continue →

Topics: rare cells, volume reduction, VRNxT

06/19/2019

Menarini Silicon Biosystems Introduces Use of DEPArray System for Challenging Flow Cytometry Applications at CYTO Congress

Digital cell sorting technology enables greater precision and accuracy for samples with rare targets and low cell counts

continue →

Topics: deparray, cell sorting, flow cytometry, rare cells

05/30/2019

CellSearch Studies at ASCO Show Potential Predictive Role for Circulating Tumor Cells in Metastatic Breast Cancer

Liquid biopsy data reveals “intriguing” association between ESR1 mutations, HER2 alterations and prognosis

continue →

Topics: CELLSEARCH, Liquid biopsy, Precision Medicine, metastatic breast cancer

03/27/2019

New CellSearch Data To Be Presented at AACR Deepens Understanding of Metastatic Breast Cancer

Northwestern Researchers Use Gold-Standard Liquid Biopsy Technology to Identify Potential New Biomarker

continue →

Topics: deparray, CELLSEARCH, Liquid biopsy, Precision Medicine, metastatic breast cancer, lynphoma, CTC cluster, melanoma

03/12/2019

Menarini Silicon Biosystems Develops New Assay Workflow for Circulating Multiple Myeloma Cells

Technology to Be Introduced at the Molecular Medicine Tri-Conference May Offer Alternative to Invasive Bone Marrow Biopsy for Monitoring Disease Progression

continue →

Topics: FFPE, deparray, CELLSEARCH, Liquid biopsy, Precision Medicine, Multiple myeloma, CMMCs

11/29/2018

New Studies Using CELLSEARCH Circulating Tumor Cell Test to be Featured at San Antonio Breast Cancer Symposium

Research Adds to Growing Evidence of Clinical Utility of CTCs for the management of Metastatic Breast Cancer Patients

continue →

Topics: CTCs, CELLSEARCH, Liquid biopsy, Precision Medicine, metastatic breast cancer

11/27/2018

Single-Cell Genomic Analysis of Blood Cancers to be Highlighted at American Society of Hematology Meeting

DEPArray Technology Used for Detection and Isolation of Lymphoma and Multiple Myeloma Cells

continue →

Topics: single-cell isolation, deparray, copy number alteration, Multiple myeloma, classical Hodgkin Lymphoma, Reed-Sternberg (HRS) Cells